hepadvax
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2017 (NCT03038802)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Hepatitis B virusImmunity, active
Hepatitis B virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hepadvax
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03038802 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2017 | Australian Respiratory and Sleep Medicine Institute, Flinders University, Vaxine Pty Ltd |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Australian Respiratory and Sleep Medicine Institute | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Flinders University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Vaxine Pty Ltd | For profit | 1 | 1 | 1 | 2017 |
3 organizations
Page 1 / 1